Social Vulnerability Index Linked to Risk for Alzheimer Disease
By Elana Gotkine HealthDay Reporter
TUESDAY, April 1, 2025 -- Individuals who live in areas with a higher social vulnerability index (SVI) have an increased risk for incident Alzheimer disease (AD) and a faster rate of cognitive decline, according to a study published online March 26 in Neurology.
Pankaja Desai, Ph.D., from Rush University Medical Center in Chicago, and colleagues conducted a secondary analysis of data from the Chicago Health and Aging Project to examine the association between SVI and risk for incident AD and rate of cognitive decline. The study included 6,781 participants aged 65 years and older at enrollment (mean age, 72 years) who lived Chicago communities representing 24 U.S. census tracts.
More than 90 percent of Black participants were in tracts ≥50 percentile SVI and about 87 percent of White participants were in tracts ≤50 percentile SVI. The researchers found that participants in tracts with SVI >50th to 75th percentile and >75th percentile had odds ratios of 2.23 and 2.04, respectively, for clinical AD. Greater incident AD risk was seen for participants in more versus less vulnerable tracts. For participants below the 25th percentile SVI, the annual rate of global cognitive decline was 0.055 standard deviation units (SDU). Compared with participants below the 25th percentile SVI, those in the 50th to 75th percentile and >75th percentile had a faster annual rate of cognitive decline by 0.010 and 0.014 SDU, respectively (approximately 18 and 25 percent faster).
"Prioritizing communities experiencing more social vulnerability may be an effective way to mobilize resources for older adults who need specific services," the authors write. "Such community programs might provide avenues for reducing AD risk at a population level."
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Cognitive Functional Therapy Effective for Chronic Low Back Pain at Three Years
WEDNESDAY, Aug. 6, 2025 -- Cognitive functional therapy (CFT), with or without biofeedback, is more effective than usual care for treating patients with chronic disabling low back...
Avoidable All-Cause Hospitalization, ED Visits Common in Nursing Homes
MONDAY, Aug. 4, 2025 -- Among severely impaired and terminally ill nursing home (NH) residents, all-cause hospitalizations (ACH) and emergency department visits without...
Average Time to Diagnosis Is 3.5 Years Across All Types of Dementia
FRIDAY, Aug. 1, 2025 -- The mean time to diagnosis (TTD) for dementia is 3.5 years across all types of dementia, according to a review published online July 27 in the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.